Defective Bactericidal Activity in PI3K p110δ Mutant Macrophages Contributes to the Development of Colitis

被引：0
|
作者：
Steinbach, Erin [1 ]
Uno, Jennifer [1 ]
Russo, Steven [1 ]
Plevy, Scott [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
来源：
CLINICAL IMMUNOLOGY | 2010年 / 135卷
关键词：
D O I：
10.1016/j.clim.2010.03.128
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [11] Non-redundant involvement of the PI3K isoforms p110γ and p110δ in the development and survival of myeloid cells
    Bucher, Kirsten
    Schmitt, Fee
    Autenrieth, Stella
    Nuernberg, Bernd
    Beer-Hammer, Sandra
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S32 - S32
  • [12] Cyclooxygenase-2 Deficiency in Macrophages Leads to Defective p110γ PI3K Signaling and Impairs Cell Adhesion and Migration
    Diaz-Munoz, Manuel D.
    Osma-Garcia, Ines C.
    Iniguez, Miguel A.
    Fresno, Manuel
    [J]. JOURNAL OF IMMUNOLOGY, 2013, 191 (01): : 395 - 406
  • [13] The role of the p110δ subunit of PI3K in the development of regulatory B cells
    Newman, R.
    Bell, S.
    Turner, M.
    [J]. IMMUNOLOGY, 2013, 140 : 61 - 62
  • [14] Involvement of the p110α Isoform of PI3K in Early Development of Mouse Embryos
    Xu, Xiao-Yan
    Zhang, Zhe
    Su, Wen-Hui
    Zhang, Yang
    Feng, Chen
    Zhao, Hong-Mei
    Zong, Zhi-Hong
    Cui, Cheng
    Yu, Bing-Zhi
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 2009, 76 (04) : 389 - 398
  • [15] Enhanced Akt phosphorylation and myogenic differentiation in PI3K p110β-deficient myoblasts is mediated by PI3K p110α and mTORC2
    Matheny, Ronald W., Jr.
    Lynch, Christine M.
    Leandry, Luis A.
    [J]. GROWTH FACTORS, 2012, 30 (06) : 367 - 384
  • [16] Enhanced PI3K p110α Signaling Confers Acquired Lapatinib Resistance That Can Be Effectively Reversed by a p110α-Selective PI3K Inhibitor
    Brady, Samuel W.
    Zhang, Jian
    Seok, Daniel
    Wang, Hai
    Yu, Dihua
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 60 - 70
  • [17] Human tumor mutants in the p110α subunit of PI3K
    Liu, Zhenning
    Roberts, Thomas M.
    [J]. CELL CYCLE, 2006, 5 (07) : 675 - 677
  • [18] p110 δ PI3K as a therapeutic target of solid tumours
    Xenou, Lydia
    Papakonstanti, Evangelia A.
    [J]. CLINICAL SCIENCE, 2020, 134 (12): : 1377 - 1397
  • [19] Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
    Zhang, Biqin
    Luk, Cheukyau
    Valadares, Joyce
    Aronis, Christos
    Foukas, Lazaros C.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (23)
  • [20] Protein quantitation assays for Akt, PI3K p110α, and PTEN to assess PI3K pathway activity in tumor tissue
    Sobsey, Constance A.
    Popp, Robert
    Ibrahim, Sahar
    Froehlich, Bjoern C.
    Aguilar-Mahecha, Adriana
    Basik, Mark
    Batist, Gerald
    Borchers, Christoph
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 51 - 52
12345